BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 31861156)

  • 1. Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes.
    Grieco GE; Brusco N; Licata G; Nigi L; Formichi C; Dotta F; Sebastiani G
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31861156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Landscape of microRNAs in βCell: Between Phenotype Maintenance and Protection.
    Grieco GE; Brusco N; Licata G; Fignani D; Formichi C; Nigi L; Sebastiani G; Dotta F
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of MicroRNAs in Diabetes and Its Complications.
    Wu B; Miller D
    Methods Mol Biol; 2017; 1617():225-239. PubMed ID: 28540689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight into miRNAs related with glucometabolic disorder.
    Zhang BH; Shen CA; Zhu BW; An HY; Zheng B; Xu SB; Sun JC; Sun PC; Zhang W; Wang J; Liu JY; Fan YQ
    Biomed Pharmacother; 2019 Mar; 111():657-665. PubMed ID: 30611990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs as therapeutic targets for the treatment of diabetes mellitus and its complications.
    Regazzi R
    Expert Opin Ther Targets; 2018 Feb; 22(2):153-160. PubMed ID: 29257914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs as stress regulators in pancreatic beta cells and diabetes.
    LaPierre MP; Stoffel M
    Mol Metab; 2017 Sep; 6(9):1010-1023. PubMed ID: 28951825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs, Parkinson's Disease, and Diabetes Mellitus.
    Wang H
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus, a microRNA-related disease?
    Guay C; Roggli E; Nesca V; Jacovetti C; Regazzi R
    Transl Res; 2011 Apr; 157(4):253-64. PubMed ID: 21420036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory Roles of MicroRNAs in Diabetes.
    Feng J; Xing W; Xie L
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1.
    Yildirim SS; Akman D; Catalucci D; Turan B
    Cell Biochem Biophys; 2013; 67(3):1397-408. PubMed ID: 23723006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus.
    Hashimoto N; Tanaka T
    J Hum Genet; 2017 Feb; 62(2):141-150. PubMed ID: 27928162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An 'alpha-beta' of pancreatic islet microribonucleotides.
    Dalgaard LT; Eliasson L
    Int J Biochem Cell Biol; 2017 Jul; 88():208-219. PubMed ID: 28122254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular aspects of pancreatic β-cell dysfunction: Oxidative stress, microRNA, and long noncoding RNA.
    Saeedi Borujeni MJ; Esfandiary E; Baradaran A; Valiani A; Ghanadian M; Codoñer-Franch P; Basirat R; Alonso-Iglesias E; Mirzaei H; Yazdani A
    J Cell Physiol; 2019 Jun; 234(6):8411-8425. PubMed ID: 30565679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs as pharmacological targets in diabetes.
    Mao Y; Mohan R; Zhang S; Tang X
    Pharmacol Res; 2013 Sep; 75():37-47. PubMed ID: 23810798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamers: novel diagnostic and therapeutic tools for diabetes mellitus and metabolic diseases.
    Hu J; Ye M; Zhou Z
    J Mol Med (Berl); 2017 Mar; 95(3):249-256. PubMed ID: 27847965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular medicine of microRNAs: structure, function and implications for diabetes.
    Hennessy E; O'Driscoll L
    Expert Rev Mol Med; 2008 Aug; 10():e24. PubMed ID: 18702835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal MicroRNA-15a Transfer from the Pancreas Augments Diabetic Complications by Inducing Oxidative Stress.
    Kamalden TA; Macgregor-Das AM; Kannan SM; Dunkerly-Eyring B; Khaliddin N; Xu Z; Fusco AP; Yazib SA; Chow RC; Duh EJ; Halushka MK; Steenbergen C; Das S
    Antioxid Redox Signal; 2017 Nov; 27(13):913-930. PubMed ID: 28173719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy of microRNA and stem cell: a novel therapeutic approach for diabetes mellitus and cardiovascular diseases.
    Tyagi AC; Sen U; Mishra PK
    Curr Diabetes Rev; 2011 Nov; 7(6):367-76. PubMed ID: 21864292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting miRNA for Therapy of Juvenile and Adult Diabetic Cardiomyopathy.
    Nandi SS; Mishra PK
    Adv Exp Med Biol; 2018; 1056():47-59. PubMed ID: 29754174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological roles of microRNAs in the control of insulin secretion and action.
    Calderari S; Diawara MR; Garaud A; Gauguier D
    Physiol Genomics; 2017 Jan; 49(1):1-10. PubMed ID: 27815534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.